ABSTRACT
Mycophenolate mofetil (MMF) is a prodrug active only after its hydrolysis to mycophenolic acid (MPA). The UGT1A9 enzyme is of special interest since it is the main enzyme involved in the glucuronidation of MPA. Single nucleotide polymorphisms (SNPs) in the UGT1A9 gene may be responsible for individual differences in the pharmacokinetics of MMF. Expression levels and the activity of UGT1A9 may depend on the presence of some SNPs located in the gene promoter region (-2152C>T and -275T>A), as well as changes in the coding region (c.98T>C). The objective of this study was to evaluate the effect of allelic variants of the UGT1A9 c.98T>C polymorphism (rs72551330; g. 87289T>C) on MMF metabolism in renal transplant patients. MPA and MPA 7-O glucuronide (MPAG) levels were determined on plasma samples of kidney transplant patients (N = 39) by high-performance liquid chromatography using ultraviolet detection. DNA was isolated from leukocytes and stored at -20°C. The presence of SNPs was investigated using polymerase chain reaction, followed by amplicon sequencing. The analysis of the UGT1A9 c.98T>C polymorphism revealed that all study patients presented the TT genotype. Diverse MPA and MPAG plasma concentrations were detected, including therapeutic, subtherapeutic, and toxic levels. A standardized molecular method permitted identification of UGT1A9 c.98T>C polymorphism genotypes in the examined renal transplant patients. All individuals of the study group presented the same genotype (c.98TT) for that polymorphism. Thereby, no association between the c.98T>C polymorphism and MPA and MPAG plasma levels could be evaluated, despite different levels of these compounds being observed.
Subject(s)
Glucuronides/blood , Glucuronosyltransferase/genetics , Graft Rejection/blood , Kidney Transplantation/adverse effects , Mycophenolic Acid/analogs & derivatives , Polymorphism, Single Nucleotide , Adult , Female , Glucuronides/genetics , Graft Rejection/genetics , Humans , Male , Middle Aged , Mycophenolic Acid/blood , UDP-Glucuronosyltransferase 1A9ABSTRACT
We evaluated the response of individuals with metabolic syndrome to lifestyle modification intervention and examined the influence of the 48867A>C (Asp358Ala) IL6R (rs2228145) polymorphism on this response. Participants were randomly divided into two groups: NI, nutritional intervention; NIE, nutritional intervention and exercise practice. Intervention lasted three months and participants completed a comprehensive evaluation and had blood collected for biochemical measurements. Eighty-two sedentary individuals with at least three criteria for metabolic syndrome were included. Comparing metabolic syndrome parameters before and after intervention, a reduction of waist circumference was observed, although significant only for AA and AC genotypes. Also, a decrease in triglyceride levels was observed (significant for AA genotype individuals; for the AC genotype, only in the NIE group). Significant reduction of fasting glucose level was observed in all AA genotype individuals; for the AC genotype, only in the NI group. Systolic blood pressure showed significant reduction in AA and AC genotype individuals. After three months of lifestyle modification intervention, improvement in some of the metabolic syndrome parameters was observed, some associated with the IL6R genotype. At enrollment, participants with genotypes AA and AC showed more severe conditions regarding metabolic syndrome inclusion criteria, supporting previous reports that the A allele is a genetic risk factor. These individuals, however, had a better response to intervention compared to individuals with the CC genotype, suggesting that nutritional control and exercise practice could prevent risks associated with metabolic syndrome more efficiently in individuals bearing the A allele.
Subject(s)
Metabolic Syndrome/therapy , Polymorphism, Single Nucleotide , Receptors, Interleukin-6/genetics , Adult , Alleles , Blood Glucose/metabolism , Blood Pressure/genetics , Brazil , Cholesterol, HDL/blood , Female , Follow-Up Studies , Gene Frequency , Genotype , Humans , Life Style , Male , Metabolic Syndrome/genetics , Middle Aged , Receptors, Interleukin-6/metabolism , Triglycerides/blood , Waist CircumferenceABSTRACT
Orthodontic appliances are usually made of stainless steel, which contains metals such as nickel, chromium and iron that have been associated with DNA damage. The aim of the present study was to determine the genetic toxicity associated with orthodontic fixed appliances in twenty healthy patients (16 +/- 2.5 years) undergoing orthodontic treatment (fixed appliances - basic composition: stainless steel alloy), using the micronucleus (MN) and comet (CA) assays in buccal cells. Primary DNA damage level, as assessed by the CA, was low either before the beginning (1.5 +/- 1.05 damage index - DI) or 10 days after the placement of the orthodontic appliance (2.5 +/- 3.08 DI) and did not change significantly between these time points (p= 0.0913). Conversely, there was a significant increase in MN frequency 30 days after the beginning of the treatment (p= 0.0236). In this study, the MN assay was shown to be more sensitive than the CA. Other investigations are necessary in order to assess the genotoxic potential of orthodontic fixed appliances associated with long-term studies concerning these effects in orthodontic patients.
